Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy

Retina

Volumn 29, Issue 4, 2009, Pages 516-522

  Cho, Won Bin ^a   Oh, Se Beum ^a   Moon, Jun Woong ^a   Kim, Hyung Chan ^a  

^a Konkuk University Hospital   (South Korea)

Author keywords

Bevacizumab; Intravitreal bevacizumab; Macular edema; Panretinal photocoagulation; Proliferative diabetic retinopathy

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARGON LASER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; SIDE EFFECT; SYSTEMIC DISEASE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RETINA MACULA EDEMA; RISK FACTOR; SPECTACLES;

ADULT; AGED; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; EYEGLASSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER COAGULATION; MACULA LUTEA; MACULAR EDEMA; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS HEMORRHAGE; YOUNG ADULT;

EID: 66149129948     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31819a5fc2     Document Type: Article

References (25)

1. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS): DRS report 8. Ophthalmology 1981;88:583-600.
2. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991;98:766-785.
3. Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:741-756.
4. McDonald HR, Schatz H. Macular edema following panretinal photocoagulation. Retina 1985;5:5-10.
5. McDonald HR, Schatz H. Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1985;92:388-393.
6. Higgins KE, Meyers SM, Jaffe MJ, Roy MS, de Monasterio FM. Temporary loss of foveal contrast sensitivity associated with panretinal photocoagulation. Arch Ophthalmol 1986;104: 997-1003.
7. Aiello LM, Cavallerano J, Aiello LP. Diagnosis, management and treatment of nonproliferative diabetic retinopathy and macular edema. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, 2nd ed. Philadelphia: WB Saunders; 2000:1900 -1914.
8. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
9. Bandello F, Polito A, Pognuz DR, Monaco P, Dimastrogio-vanni A, Paissios J. Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy. Arch Ophthalmol 2006;124:643-650.
10. Jonas JB, Degenring R, Kreissig I, Akkoyun I. Safety of intravitreal high-dose reinjections of triamcinolone acetonide. Am J Ophthalmol 2004;138:1054-1055.
11. Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior sub-capsular cataract. Ophthalmology 2005;112:139-143.
12. Gillies MC, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 2004;122:336 -340.
13. Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endoph-thalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003;136:791-796.
14. Nonaka A, Kiryu J, Tsujikawa A, et al. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci 2002;43:1204-1209.
15. Tsujikawa A, Kiryu J, Dong J, et al. Quantitative analysis of diabetic macular edema after scatter laser photocoagulation with the scanning retinal thickness analyzer. Retina 1999;19:59 - 64.
16. Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E, Hori S. Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol 2003;135:321-327.
17. Del Maschio A, Zanetti A, Corada M, et al. Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol 1996;135:497-510.
18. Brooks HL Jr, Caballero S Jr, Newell CK, et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 2004;122:1801-1807.
19. Diabetic Retinopathy Clinical Research Network. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007:114:1860-1867.
20. Jorge R, Costa RA, Calucci D, Cintra LP, Scott IU. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina 2006;26:1006-1013.
21. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278.
22. Haritoglou C, Kook D, Neubauer A, et al. Intravitreal bevaci-zumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
23. Tonello M, Costa RA, Almeida FP, Barbosa JC, Scott IU, Jorge R. Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study). Acta Ophthalmol 2008;86:385-389.
24. Zacks DN, Johnson MW. Combined intravitreal injection of triamcinolone acetonide and panretinal photocoagulation for concomitant diabetic macular edema and proliferative diabetic retinopathy. Retina 2005;25:135-140.
25. Larsson J, Zhu M, Sutter F, Gilles MC. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 2005;139:802-806.